Chi Eziefula

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Clark D Russell, Cameron J Fairfield, Thomas M Drake et al. · The Lancet Microbe · 2021 · 334 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +17

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins et al. · Science Immunology · 2021 · 259 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty et al. · The Lancet Respiratory Medicine · 2021 · 196 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests

Gonzalo J. Domingo, Ari Winasti Satyagraha, Anup Anvikar et al. · Malaria Journal · 2013 · 167 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Annemarie B Docherty, Rachel Mulholland, Nazir Lone et al. · The Lancet Respiratory Medicine · 2021 · 122 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +16